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Abstract
Purpose CT-guided percutaneous transthoracic lung nee-
dle biopsy (PLB) is an effective procedure for obtaining
cyto-histological diagnoses of peripheral lesions. However,
upper postero-lateral lung nodules (UPLN) may be difficult
to reach using a standard intercostal either anterior or lat-
eral approach or when the nodule is just behind a rib or
scapula. We evaluated the feasibility and effectiveness of
trans-scapular approach (tPLB) in these patients using
large-core needles.
Methods We retrospectively collected the data of 11 con-
secutive patients (mean age 74.6 years, SD 5.9) among
those scheduled to undergo CT-guided PLB over the period
February 2015 to February 2017. In these patients, the
presence of a UPLN required a tPLB using a co-axial
technique and large full-core needles (15G for the scapular
piercing and 18–19G for tissue sampling). All patients
were assessed by telephone at 24 h, 78 h and at an office
visit at 30 days after the procedure to evaluate post-pro-
cedural pain (VAS score) and shoulder mobility.
Results Ten of the eleven samples were diagnostic. No
major complications were encountered. Three patients
developed a pneumothorax, but none required pleural
drainage. All the patients confirmed the absence of pain at
24–72 h and 30 days, reporting a VAS score less than 1,
without any shoulder mobility limitation.
Conclusion tPLB seems to be an effective and feasible
procedure, accompanied by a low risk of pneumothorax in
UPLN cases.
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Introduction
Lung cancer is the leading cause of cancer-related mor-
tality worldwide with an overall 5-year survival rate of
17% [1]. Tissue biopsy remains the gold standard for
diagnosing both malignant and non-malignant diseases and
for obtaining important information for targeted therapies.
Although flexible bronchoscopy and other endoscopic
techniques (e.g., trans-bronchial needle aspiration TBNA,
endo-bronchial ultrasounds EBUS) are the recommended
procedures for patients suspected of having lung cancer
[1, 2], surgical or percutaneous tissue biopsy is required in
some cases.
Many studies have investigated the precautions that
should be considered for reducing complications while
performing percutaneous lung biopsies (PLB) [3–5].
Pneumothorax (PTX) remains the most prevalent compli-
cation of PLB, with a reported incidence rate that ranges
from 8 to 65% [2–4]. Predicting PTX is still difficult: the
nodule depth (pleura-lesion distance), small lesion’s size,
repeated pleural punctures, crossed fissures and emphy-
sema are considered relevant risk factors for PTX associ-
ated with CT-guided PLB [3]. For these reasons, some
guidelines are recommended for performing PLB, such as
avoiding the fissures and blebs or choosing the least pleura-
lesion distance [5, 6]. However, certain pulmonary nodules
may be difficult to reach using the conventional approach,
due to their location behind osseous structures, even though
some authors have suggested trans-osseous routes [7, 8].
The previously described trans-scapular technique provides
for the use of small needles (22G). According to the lit-
erature on lung biopsies, small needles are susceptible to
similar complication rates as large needles (18–19G) [3].
We retrospectively collected the data for all patients
who had undergone CT-guided full-core PLB with a trans-
scapular approach technique (tPLB) of upper postero-lat-
eral lung nodules (UPLN) in order to assess the safety and
feasibility of the technique using large-core needles.
Materials and Methods
Study Design and Population
This retrospective non-comparative study was conducted in
a tertiary care hospital (about 300 CT-guided PLB per
year). Among patients who underwent CT-guided PLB
over the period February 2015–2017, we collected data for
all the cases in which a tPLB was performed (6 male, 5
female; mean age 74.6 years, SD 5.9). All patients gave
informed written consent prior to the procedure and waived
institutional review board (IRB) approval.
The pre-procedure evaluation included detailed history,
physical examination, blood exams and cardiopulmonary
assessment. All cases requiring PLB are discussed in the
multidisciplinary meeting. The bronchoscopist, IR and
surgeons discussed the best diagnostic option for obtaining
cytologic/histologic samples, in consultation with the
pathologist.
A bronchoscopy was unsuccessfully attempted in 4
cases, however, it was considered unfeasible in the
remaining 6 cases. A patient’s eligibility criteria for biopsy
are: platelet count [50,000/mm3, INR\ 1.5, and must
have been deemed a poor candidate for a previous non-
diagnostic trans-bronchial biopsy. The performing physi-
cian evaluated, on pre-biopsy and preliminary images, all
the variables considered to be risk factors that could lead to
complications: crossing fissures, crossing blebs, angulation
of pleural puncture, vascular structures, nodule depth etc.
The decision to perform a tPLB was taken intra-procedu-
rally, in some cases after the failure of conventional
approaches (Fig. 1).
CT-Guided TNAB with Trans-scapular Approach
Technique
All procedures used in this study were performed by two
interventional radiologists with 10 and 30 years of expe-
rience in IR. The patient was positioned prone or lying in
the lateral decubitus on the opposite side of nodule local-
ization (Fig. 1A), after having been asked to find the most
comfortable position, without conscious sedation. The
patient was instructed to breathe regularly, avoiding any
movement, and he was not required to hold his breath.
After preliminary image analysis, the entry point was
marked on the patient’s skin using a dermographic pen and
gantry’s laser pointer. Larger scapular arteries were located
on the margins of the scapular body, so peripheral entry
points on the scapula were avoided [9].
Local anesthesia (2% lidocaine) was performed with a
22G needle from the skin to the scapular cortex (Fig. 1B,
C). The periostium of the scapula was accurately infil-
trated. Once the biopsy pathway was defined, a small
incision was made to the skin, and a 15G bone marrow
biopsy needle ‘‘ERG’’ type (Selective ‘‘ERG’’ type,
ZAMAR d.o.o., Porec, Croatia) was inserted in the
scapular body using a drilling and steady pressure move-
ment (Fig. 1D) or using a surgical hammer. Then, an 18G
(Biomol, HS Hospital Service S.p.A., Aprilia, Italy) or 19G
(Hepashot, Vigeo SrL, Bagnolo San Vito, Italy) Menghini-
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type semi-automatic full-core biopsy needle (with a two cm
cutting length) was coaxially inserted and gently advanced
to the pleura (Fig. 1E) without a guiding needle. More
lidocaine was injected through the Menghini needle just
over the pleura to obtain a small meniscus for a complete
anesthesia. Then, the needle was advanced into the lesion
to collect the sample using a single movement (Fig. 1F).
A CT scan was performed after the removal of all needles
(Fig. 1G). In all cases, only one sample was obtained and
was placed in a 4% formaldehyde solution (BiopSafe,
Axlab A/S, Vedbaek, Denmark).
The procedure was performed in a day-hospital setting.
The patients were kept under observation for 6 h, and a
chest X-ray was performed 3 h after the biopsy. Vital signs
and referred symptoms were assessed prior to discharge.
Asymptomatic PTXs and/or small PTXs (\2 cm between
the lung margin and the chest wall at the level of the hilum
on the chest X-ray) were treated conservatively. A chest
tube was inserted for evacuation in patients with
PTXs[ 2 cm and/or with signs of shortness of breath or
respiratory distress [10, 11]. Significant muscle and skeletal
bleeding were assessed during and at the end of the pro-
cedure using the CT scans since such complications could
occur soon after or during the needle placement. Late
bleeding was ruled out by the complete absence of
discomfort/pain or limitation of movement at the site of the
puncture.
Data Analysis
Datawere collected on a standardized form developed for this
purpose. In addition to the identifying and demographics data,
the following procedure details were collected: scapular
thickness, scapular and pleural depth from the skin, nodule
axialmaximum diameter, distance from the pleura, number of
scans performed and radiation dose. The histological results
were collected along with the presence of complications:
pneumothorax, pulmonary hemorrhage, hemoptysis,
hemothorax, air embolism and death. All patients were
assessedby telephone at 24 h, 78 h andduringanoffice visit at
30 days following the procedure to evaluate post-procedural
pain (VAS score) and shoulder mobility.
Results
The locations of pulmonary lesions were found in the
posterior segment of the right upper lobe in 7 cases, in the
apico-posterior segment of the left upper lobe in 4 cases
Fig. 1 A Patient presenting a 33-mm nodular lesion of the right
superior lobe (arrow), pleura–lesion distance was 15 mm. Patient was
positioned lying on the left side. B A first attempt of PLB was made
passing between the anterior margin of the scapula and a rib, note the
22G needle for anesthesia (arrow). Even moving the patient arm did
not allow a constant open needle track. C Consequently, we decided
to perform a trans-scapular access. Note the second 22G needle used
for local anesthesia near the scapular body. D A 15G bone marrow
biopsy needle Selective ‘‘ERG’’ type was inserted in the scapular
body (arrow). E Then, an 18G Menghini-type semi-automatic full-
core biopsy needle was coaxially inserted and gently advanced to the
parietal pleura (arrow), where more local anesthesia was injected.
F The Menghini needle was firmly advanced in one movement into
the lesion (arrow). A CT scan confirmed the needle placement in the
lesion, and then the sample was gathered. G Post-procedure CT scan
performed after the removal of all needles showed the absence of
PTX, note small air bubbles on the external side of parietal pleura, site
of anesthesia
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and in the apical segment of the left inferior lobe in one
case. The mean scapular thickness, lesion’s axial maximum
diameter, scapular and pleural depth from the skin were,
respectively, 2.0, 28.2, 30 and 50 mm (ranges 1.4–2; 20–3;
26–3; 45–57 mm, respectively). In 4 cases, the lesion was
adherent to the pleura, while in the remaining 7 cases the
mean distance between the pleura and the lesion was
6.9 mm (range 4–15 mm).
The histology of such pulmonary nodules was of ade-
nocarcinoma in eight cases. In one of them, the sample was
insufficient for diagnosis (adenocarcinoma was diagnosed
on the surgical specimen). The remaining three patients
had a squamous cell carcinoma. All the samples allowed
for gene mutational analysis except for the one with
insufficient material for diagnosis.
Two patients showed a 1- and 4-mm PTX layer on the
CT scan performed after the needle removal. At the 3-h
thoracic X-ray, the pneumothorax disappeared in one
patient and increased in the other one (from 1 to 25 mm),
while a third patient developed a 13-mm pneumothorax.
None of the patients required a pleural evacuation. Data are
summarized in Table 1. Only one case of pulmonary
hemorrhage was present on the post-procedure CT. No
cases of either minor or major complications were
encountered [12]. All the patients confirmed the absence of
pain at 24–72 h and 30 days, reporting a VAS score less
than 1, without any shoulder mobility limitation.
Discussion
The overall amount of PLB has increased in recent years
due to the evolution of clinical oncology and its related
new demands [13, 14]. The detection of lung nodules
during screening [15] or unrelated reasons has increased
with the diffusion of CT scanners. Moreover, the devel-
opment of targeted therapies has led to an increasing
demand for molecular tissue characterization and re-char-
acterization [16] which has enabled practitioners to direct
patients to the most appropriate treatment option according
to tumor bioprofile [13, 14, 17].
A UPLN could be a challenging target for a biopsy. The
anterior approach increases the pleura–lesion distance with
a higher risk of PTX due to the length of traversed par-
enchyma [18]. As a result, the subclavian neurovascular
bundle must be avoided. The major fissure often lies in the
biopsy needle path if target lesions are located in the
superior segment of the lower lobe [3–5]. In some cases, a
very angulated needle insertion, tangentially to the pleural
surface, may be repeatedly required in cases of unsuc-
cessful tissue or cytologic collection [6]. Therefore, the
posterior approach with the patient in prone position is
often preferred, particularly for posterior lesions. However,
in select patients the presence of ribs and scapula can be a
technical obstacle for the subpleural UPLNs. Ribs, and
similarly the edge of the scapula, can usually be avoided by
angulating the needle. In such cases, the angulation of CT
gantry may be of help to the operator. TBNA and other
bronchoscopic techniques revealed good results in lung
tumor sampling. Even so, peripheral or subpleurical lesions
could be challenging for these techniques. The UPLNs
considered in this study were adherent to the pleura in 4
cases and at an average distance of 7 mm from the pleura
in the remaining cases. Such sites could often be difficult
using bronchoscopy [2].
If the nodules are underneath the scapular body, a direct
nodule biopsy could be obtained with trans-scapular
access; an average of 300 PLB are performed at our
institution, and 11 tPLB in 2 years represent about the 2%
of the procedures. In effect, the low incidence hampers
rapid learning curves. Regardless, the use of co-axial
technique should be part of the interventional radiologists’
regular daily practice.
In this series, the trans-scapular approach reduced this
pleura-lesion distance to zero in 5 cases, since the nodule
had a pleural contact, and to a mean of 7 mm in the
remaining cases. Moreover, in the case of severe emphy-
sema, the presence of bullae, surrounding a subpleural
lesion, could decrease the spectrum of options for safe
direct access. In fact, a trans-scapular approach could be
the only way to obtain a safe route. The pneumothorax rate
is about 25% in a large meta-analysis accompanied by 5%
requiring intervention [3]. The present study PTX rate
overlaps these data (27%—3/11); however, no intervention
was required. Moreover, there was no case of hemoptysis
and just one case (9%) of pulmonary hemorrhage, showing
a reduction in such complications, which represent,
respectively, about 4 and 18% of cases [3]. In all these
patients, the complication observed was asymptomatic. So,
these patients were discharged in the late afternoon with
the warning to advise the hospital staff or to come back to
the institution if any respiratory or correlated symptom
occurred (e.g., hemoptysis or dyspnea) (Fig. 2).
Rossi et al performed the trans-scapular approach in five
patients using a co-axial technique penetrating the scapular
bone with an 18G two-piece guide needle [8]. Following
this, a 22G biopsy needle was used for cytological sample
collection. In our experience, we opted for larger needles,
both for trans-scapular piercing and sample collection.
Recent studies have demonstrated that both fine-needle and
core biopsy have a similar complication rate [3, 19]. With
regard to the possibility of tumor seeding, since the tech-
nique provides the placement of a trans-bone cannula up to
the pleural surface, the needle that crosses the tumor does
not actually cross the thoracic wall. As a result, we cannot
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Table 1 Population and procedure characteristics
Patient Sex Age Side Lesion
diameter
Skin–pleura
distance (mm)
Skin–scapula
distance (mm)
Pleura–nodule
distance (mm)
Scapular
thickness
(mm)
Periprocedural
complications
(PTX in mm)
3 h chest X-ray
(PTX in mm)
1 F 80 R 25 49 31 0 1.4 0 0
2 M 78 R 33 57 31 15 2 0 13
3 M 71 R 33 50 28 0 2.5 1 25
4 F 74 L 25 46 30 0 1.8 0 0
5 M 69 R 34 48 26 6 2.1 0 0
6 M 81 R 22 53 29 8 2 0 0
7 F 67 L 20 47 32 0 2 0 0
8 F 78 L 35 55 28 5 1.7 0 0
9 M 82 L 29 52 33 4 2.3 0 0
10 M 65 L 28 45 35 6 1.5 4 0
11 F 76 R 26 48 27 4 2.2 0 0
Mean 74.6 28.2 50.0 30.0 4.4 2.0 0.5 3.5
SD 5.9 5.1 3.8 2.7 4.6 0.3 1.2 8.1
Max 82.0 35.0 57.0 35.0 15.0 2.5 4.0 25.0
Min 65.0 20.0 45.0 26.0 0.0 1.4 0.0 0.0
PTX pneumothorax; SD standard deviation; L left; R right
Fig. 2 A Lung contrast-enhanced CT scan performed on a patient
presenting a 33-mm nodular lesion of the right superior lobe in
contact with the pleura, 40 days prior to the biopsy. Note the long
path required supposing an anterior approach, a lateral approach
required an acute angle piercing the pleura, while the posterior
approach was hampered by the fissure (white arrow heads). B Patient
was positioned prone the day of the procedure, the position of the
fissure and of the ribs was confirmed, and the trans-scapular approach
was preferred. C, D A 15G bone marrow biopsy needle Selective
‘‘ERG’’ type was inserted in the scapular body. E Then, a 19G
Menghini-type semi-automatic full-core biopsy needle was coaxially
inserted and gently advanced to the parietal pleura. The Menghini
needle was firmly advanced in one movement in the lesion (arrow).
F A CT scan confirmed the needle placement in the lesion. G Post-
procedure CT scan performed after the removal of all needles shows
the absence of PTX. Note small air bubbles on the external side of
parietal pleura and intercostal muscles, site of anesthesia. H Post-
procedure 3 h chest X-ray in expiratory projection showing a delayed
development of a 25-mm PTX (arrow heads), but pleural drainage
was not required. The patient was discharged in the late afternoon
with the warning to advise the hospital staff or to come back to the
institution if any respiratory or correlated symptom occurred
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expect a significant increased risk of seeding as compared
to the standard technique.
Due to the increase in requests for molecular profiling of
lung cancer [13, 14, 16], we prefer the use of 18G core
needles to obtain a larger amount of tissue. Non-surgical
histologic biopsies are considered to have a higher diag-
nostic yield, although some authors reported a comparable
diagnostic accuracy for needle aspiration [19]. However,
there are no studies available comparing the diagnostic
yield of fine-needle or core biopsy in the diagnosis of
molecular predictive markers, nor quantifying the amount
of tumoral tissue obtained [20]. Consequently, more evi-
dence is necessary and further focused research should be
encouraged.
The use of two needles for performing the biopsy could
raise some concerns about the cost and timing of the pro-
cedure. Considering the low rate of nodules requiring this
approach, the overall cost can easily be absorbed into the
biopsies performed per year. Moreover, the risk of insuf-
ficient sampling, accompanied by the necessity to repeat
the procedure, or the cost of complication management
could reasonably justify the relatively low cost addition to
the procedure. The procedure time does not seem to be
longer than the time usually required for difficult nodule
localizations.
Considering the mean scapular thickness of 2 mm
reported in our study, the use of a 15G bone marrow biopsy
needle ensures easier penetration; however, notwithstanding,
we had to resort to using a surgical hammer twice to succeed
in scapular penetration. Moreover, the 15G needle ensures
some degrees of steering during the co-axial introduction of
the 18G one. This could be useful considering the inability
to steer the first needle once inserted in the scapula.
According to the other available series [7, 8], none of the
patients reported bleeding or other complications after the
scapula penetration, even with the use of a 15G needle.
This technique seemed to be well tolerated if an optimal
anesthetic infiltration of the anterior and posterior perios-
tium of the scapular body and of the pleura was performed.
This appears to be a key measure when performing the
procedure and avoids the need for conscious sedation or
intravenous analgesia. Local anesthesia can be easily
achieved on the posterior surface of the scapular body with
the 22G needle. The anterior surface can be anesthetized
through the 15G needle just after anterior cortex piercing,
without causing significant discomfort to the patient. Also
during the follow-up, all patients experienced an absence of
pain associated with unchanged shoulder mobility.
The small number of patients enrolled limits this. In our
experience, enrolling a large series of patients in order to
set up prospective, randomized studies that compare the
trans-scapular approach to the conventional PLB is a dif-
ficult task due to the limited need for trans-scapular access
in our institution. Even so, further studies are needed to
confirm these preliminary data. The lesions in this paper
had a relatively large mean diameter (28 mm), which could
influence the high reported diagnostic rate, but still allows
a valid evaluation of its feasibility.
In summary, this study supports the feasibility and
safety of the tPLB using full-core biopsy needles, accom-
panied by a low risk of PTX and a promising diagnostic
accuracy. Excessively challenging conventional approa-
ches to UPLN could be converted to trans-scapular
approach with minor concerns.
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of the Superior Lobes Using Large Needles
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Jacopo Vannucci2 • Giulio Metro4 • Antonio Basile5 • Michele Duranti3 •
Michele Rossi6
! Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2017
Erratum to: Cardiovasc Intervent Radiol
DOI 10.1007/s00270-017-1768-0
In the published article, Michele Rossi mistakenly appears
as the next to the last name in the author list. Michele Rossi
should appear as the last name in the author list as shown in
this erratum.
The online version of the original article can be found under doi:
10.1007/s00270-017-1768-0.
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